Clinical trial

A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green

NCT06768268

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2025-01-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2025-01-01Date precision: day

Registry last updated2025-04-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Early Stage Breast Cancer (Stage 1-3)unresolved

Interventions

Voluven-assisted Indocyanine green fluorescence guided sentinel lymph node biopsy for breast cancerPROCEDURE

Mannitol (20%)DRUG

Sponsors & collaborators

National Taiwan University Hospitallead sponsor

National Yang Ming Chiao Tung Universitycollaborator

National Taiwan University Hospital Hsin-Chu Branchcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06768268 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.